TotalMarketCap

RedHill Biopharma

RDHLNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.733 M

$0.42 -0.47%

Close of 6 Nov 2026

As of 6 Nov 2026, RedHill Biopharma (RDHL) has a market capitalization of $3.73M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

50,923,261,000

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #460NuCanaNCNA$3.89M
  2. #461Dermata TherapeuticsDRMA$3.82M
  3. #462RedHill BiopharmaRDHL$3.73M
  4. #463Cadrenal TherapeuticsCVKD$3.57M
  5. #464GRI BioGRI$3.45M

What if RedHill Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,177,079

Per share 7,564,474× higher

Bitcoin $1.53T

$171,906.22

Per share 409,301× higher

Apple $5.02T

$564,352.08

Per share 1,343,695× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for RedHill Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.